TRNS
TRNS
Transcat, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $83.86M ▲ | $25.16M ▲ | $-1.1M ▼ | -1.31% ▼ | $-0.12 ▼ | $7.19M ▼ |
| Q2-2025 | $82.27M ▲ | $23.26M ▲ | $1.27M ▼ | 1.54% ▼ | $0.14 ▼ | $9.79M ▼ |
| Q1-2025 | $77.13M | $18.97M | $4.46M | 5.79% | $0.48 ▼ | $12.35M |
| Q4-2024 | $77.13M ▲ | $18.97M ▲ | $4.46M ▲ | 5.79% ▲ | $0.49 ▲ | $12.35M ▲ |
| Q3-2024 | $67.83M | $17.47M | $3.29M | 4.84% | $0.36 | $8.19M |
What's going well?
Revenue is still growing, even if slowly. The company avoided any big one-time charges, and the share count is stable, so dilution isn't an issue.
What's concerning?
Costs are rising much faster than sales, squeezing margins and pushing the company into the red. Operating efficiency is slipping, and profitability has taken a big hit.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $3.47M ▼ | $472.89M ▼ | $176.12M ▼ | $296.77M ▲ |
| Q2-2025 | $5.08M ▲ | $484.89M ▲ | $189.47M ▲ | $295.42M ▲ |
| Q1-2025 | $1.86M ▲ | $392.54M ▲ | $100M ▲ | $292.54M ▲ |
| Q4-2024 | $1.52M ▼ | $385.24M ▼ | $98.36M ▼ | $286.88M ▲ |
| Q3-2024 | $4.64M | $386.01M | $104.93M | $281.08M |
What's financially strong about this company?
The company has a solid equity base, manageable debt, and enough current assets to cover short-term bills. Retained earnings show a profitable history.
What are the financial risks or weaknesses?
Cash is low, and most assets are tied up in goodwill and intangibles, which could be written down if acquisitions don't perform. Liquidity is getting tighter, and PP&E dropped sharply.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-1.1M ▼ | $12.17M ▼ | $-2.68M ▲ | $-12.21M ▼ | $-1.61M ▼ | $9.49M ▲ |
| Q2-2025 | $1.27M ▼ | $12.86M ▲ | $-86.96M ▼ | $77.25M ▲ | $3.22M ▲ | $8.42M ▲ |
| Q1-2025 | $3.26M ▼ | $3.62M ▼ | $-4.6M ▼ | $1.95M ▲ | $344K ▲ | $-975K ▼ |
| Q4-2024 | $4.46M ▲ | $10.63M ▼ | $-4.04M ▲ | $-9.45M ▼ | $-3.12M ▲ | $7.93M ▼ |
| Q3-2024 | $2.36M | $12.6M | $-72.01M | $39.65M | $-19.18M | $9.73M |
What's strong about this company's cash flow?
The company produces more cash from its operations than it reports as profit, showing high-quality earnings. Free cash flow is growing, and the business is not dependent on outside funding.
What are the cash flow concerns?
The cash balance is low, giving little room for error if business slows or unexpected costs arise. Working capital improvements may be temporary, and receivables are rising.
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Distribution Service | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ |
Service | $50.00M ▲ | $50.00M ▲ | $50.00M ▲ | $50.00M ▲ |
Revenue by Geography
| Region | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
CANADA | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
UNITED STATES | $70.00M ▲ | $70.00M ▲ | $80.00M ▲ | $80.00M ▲ |
Q3 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Transcat, Inc.'s financial evolution and strategic trajectory over the past five years.
Transcat combines steady revenue growth, rising profitability, and strong cash generation with a defensible niche in highly regulated calibration markets. Its extensive accreditations, long-standing customer relationships, and dual services-plus-distribution model provide multiple touchpoints with clients. The growing suite of proprietary and acquired software tools, along with an expanding network of labs, enhances customer stickiness and supports recurring, mission-critical work.
The main risks are financial and strategic in nature. The balance sheet has become more leveraged and less liquid as the company has accelerated acquisitions and capital spending, increasing exposure to integration missteps and cyclical shocks. Operating costs, particularly overhead, have been rising faster than revenue, which could erode margins if not controlled. Heavy reliance on acquired intangibles and the absence of a clear R&D line also raise questions about how consistently the firm is investing in organic innovation versus buying growth.
Overall, the outlook appears constructive but execution-dependent. Transcat is operating in markets where accuracy, compliance, and uptime are non-negotiable, which tends to support steady demand even through economic cycles. If management can integrate acquisitions smoothly, keep leverage at a prudent level, and translate digital initiatives into higher-value services, the company is well positioned to continue compounding its scale and cash flows. Conversely, sustained cost escalation, misjudged deals, or underinvestment in evolving technology would be the main factors that could temper that trajectory.
About Transcat, Inc.
https://www.transcat.comTranscat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $83.86M ▲ | $25.16M ▲ | $-1.1M ▼ | -1.31% ▼ | $-0.12 ▼ | $7.19M ▼ |
| Q2-2025 | $82.27M ▲ | $23.26M ▲ | $1.27M ▼ | 1.54% ▼ | $0.14 ▼ | $9.79M ▼ |
| Q1-2025 | $77.13M | $18.97M | $4.46M | 5.79% | $0.48 ▼ | $12.35M |
| Q4-2024 | $77.13M ▲ | $18.97M ▲ | $4.46M ▲ | 5.79% ▲ | $0.49 ▲ | $12.35M ▲ |
| Q3-2024 | $67.83M | $17.47M | $3.29M | 4.84% | $0.36 | $8.19M |
What's going well?
Revenue is still growing, even if slowly. The company avoided any big one-time charges, and the share count is stable, so dilution isn't an issue.
What's concerning?
Costs are rising much faster than sales, squeezing margins and pushing the company into the red. Operating efficiency is slipping, and profitability has taken a big hit.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $3.47M ▼ | $472.89M ▼ | $176.12M ▼ | $296.77M ▲ |
| Q2-2025 | $5.08M ▲ | $484.89M ▲ | $189.47M ▲ | $295.42M ▲ |
| Q1-2025 | $1.86M ▲ | $392.54M ▲ | $100M ▲ | $292.54M ▲ |
| Q4-2024 | $1.52M ▼ | $385.24M ▼ | $98.36M ▼ | $286.88M ▲ |
| Q3-2024 | $4.64M | $386.01M | $104.93M | $281.08M |
What's financially strong about this company?
The company has a solid equity base, manageable debt, and enough current assets to cover short-term bills. Retained earnings show a profitable history.
What are the financial risks or weaknesses?
Cash is low, and most assets are tied up in goodwill and intangibles, which could be written down if acquisitions don't perform. Liquidity is getting tighter, and PP&E dropped sharply.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-1.1M ▼ | $12.17M ▼ | $-2.68M ▲ | $-12.21M ▼ | $-1.61M ▼ | $9.49M ▲ |
| Q2-2025 | $1.27M ▼ | $12.86M ▲ | $-86.96M ▼ | $77.25M ▲ | $3.22M ▲ | $8.42M ▲ |
| Q1-2025 | $3.26M ▼ | $3.62M ▼ | $-4.6M ▼ | $1.95M ▲ | $344K ▲ | $-975K ▼ |
| Q4-2024 | $4.46M ▲ | $10.63M ▼ | $-4.04M ▲ | $-9.45M ▼ | $-3.12M ▲ | $7.93M ▼ |
| Q3-2024 | $2.36M | $12.6M | $-72.01M | $39.65M | $-19.18M | $9.73M |
What's strong about this company's cash flow?
The company produces more cash from its operations than it reports as profit, showing high-quality earnings. Free cash flow is growing, and the business is not dependent on outside funding.
What are the cash flow concerns?
The cash balance is low, giving little room for error if business slows or unexpected costs arise. Working capital improvements may be temporary, and receivables are rising.
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Distribution Service | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ |
Service | $50.00M ▲ | $50.00M ▲ | $50.00M ▲ | $50.00M ▲ |
Revenue by Geography
| Region | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
CANADA | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
UNITED STATES | $70.00M ▲ | $70.00M ▲ | $80.00M ▲ | $80.00M ▲ |
Q3 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Transcat, Inc.'s financial evolution and strategic trajectory over the past five years.
Transcat combines steady revenue growth, rising profitability, and strong cash generation with a defensible niche in highly regulated calibration markets. Its extensive accreditations, long-standing customer relationships, and dual services-plus-distribution model provide multiple touchpoints with clients. The growing suite of proprietary and acquired software tools, along with an expanding network of labs, enhances customer stickiness and supports recurring, mission-critical work.
The main risks are financial and strategic in nature. The balance sheet has become more leveraged and less liquid as the company has accelerated acquisitions and capital spending, increasing exposure to integration missteps and cyclical shocks. Operating costs, particularly overhead, have been rising faster than revenue, which could erode margins if not controlled. Heavy reliance on acquired intangibles and the absence of a clear R&D line also raise questions about how consistently the firm is investing in organic innovation versus buying growth.
Overall, the outlook appears constructive but execution-dependent. Transcat is operating in markets where accuracy, compliance, and uptime are non-negotiable, which tends to support steady demand even through economic cycles. If management can integrate acquisitions smoothly, keep leverage at a prudent level, and translate digital initiatives into higher-value services, the company is well positioned to continue compounding its scale and cash flows. Conversely, sustained cost escalation, misjudged deals, or underinvestment in evolving technology would be the main factors that could temper that trajectory.

CEO
Jaime A. Irick
Compensation Summary
(Year 2025)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 1997-07-23 | Forward | 2:1 |
| 1982-08-03 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 94
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
NSB ADVISORS LLC
Shares:1.42M
Value:$108.56M
CONESTOGA CAPITAL ADVISORS, LLC
Shares:974.74K
Value:$74.54M
NEUBERGER BERMAN GROUP LLC
Shares:877.67K
Value:$67.12M
Summary
Showing Top 3 of 197

